CME Presentations

Major Depressive Disorder


Presentations


Speakers

  • Larry Culpepper, MD

    Larry Culpepper, MD

    Larry Culpepper, MD

    Professor of Family Medicine

    Larry Culpepper, MD, is a professor of family medicine and the founding chairman of the Department of Family Medicine at Boston University. He received his MD from Baylor College of Medicine and his MPH from Boston University. Dr Culpepper has conducted federally funded studies of depression and anxiety, otitis media, and school- and community-based interventions to improve pregnancy outcomes and to prevent teen pregnancies. He is a member of the Depression and Bipolar Support Alliance, the Anxiety and Depression Association of America, and the National Sleep Foundation Scientific Advisory Boards and is the editor of the Primary Care Companion for CNS Diseases. He served as president of the North American Primary Care Research Group and was co-PI of the Primary Care Anxiety Project.
  • Michael E. Thase, MD

    Michael E. Thase, MD

    Michael E. Thase, MD

    Professor of Psychiatry

    Michael E. Thase, MD, is professor of psychiatry and director of the Mood and Anxiety Section in the department of psychiatry at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and directs the Mood Disorders Research studies at the Philadelphia Veterans Affairs Medical Center. Dr Thase’s research focuses on the assessment and treatment of mood disorders, including studies of the differential therapeutics of both depression and bipolar affective disorder. He has authored or co-authored 16 books, numerous scientific articles and book chapters, and is involved in several professional organizations that include the American Psychiatric Association, the American Society of Clinical Psychopharmacology, and the National Depression and Bipolar Support Alliance.

CME Information

Major Depressive Disorder: Improving Patient Outcomes with Shared Decision-Making


PIM Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Summarize the principles of SDM and apply them to the management of patients with MDD who are candidates for psychopharmacologic therapies
  • Compare and contrast the unique mechanisms of action and clinical characteristics of new and emerging therapies, including clinical trial data and real life experiences, as they apply to SDM and individualized treatment in patients with MDD
  • Incorporate SDM principles and knowledge of the clinical characteristics of psychopharmacologic therapies to the management of complex patients with MDD in real life settings, including treatment selection, setting of treatment goals, appropriate monitoring, and optimal management of nonadherence and refractory disease

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Otsuka, Alkermes, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.

Tuition

Complimentary

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Physician Continuing Education
Live Internet Activity

Primary Care Network designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Online On-Demand Enduring Material

Primary Care Network designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals will be issued a certificate of participation.

Primary Care Network has been awarded Accreditation with Commendation (2013-2019) by the Accreditation Council for Continuing Medical Education (ACCME).

Date of Release/Expiration

Live Activity
Wednesday March 13, 2019 from 10:00am – 11:00am EST.

Enduring Material
The enduring material will be available from March 13, 2019 – March 13, 2020.

Target Audience

This program is primarily intended for psychiatrists, psychologists, family physicians, internal medicine physicians, advanced practice providers, nurses, pharmacists, and other HCPs involved in the care of patients with MDD.

Estimated Time to Complete

This activity consists of one session which should take approximately 1 hour to complete.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go www.PsychiatryCareLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the pre and post-test and activity evaluation. Participants must receive a minimum score of 70% on the post-test in order to receive a certificate.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Statement of Disclosure and Independence

It is the policy of Primary Care Network (PCN) to ensure all of its accredited educational activities are planned, developed, and conducted in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Essential Areas and Policies. In accordance with ACCME requirements, PCN has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that PCN accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.

PCN’s Resolution of Personal COI Policy aims to ensure that all potential conflicts are identified and resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a PCN accredited Continuing Medical Education (CME) activity are considered Planning Committee Members. Planning Committee Members include individuals involved in a CME activity who may develop, edit, review and/or present content. Planning Committee Members are required to disclose to the participants any real or apparent conflict(s) of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.

The faculty reported the following relevant financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Presenters

Michael E. Thase, MD
Reported Relevant Financial Relationship:
Consultant: Allergan, Inc., Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corp., Otsuka Pharmaceutical, Pfizer, Inc., Sunovion Pharmaceuticals, Inc., Acadia, Inc., Akili, Inc., Alkermes PLC, Cerecor, Inc., Fabre-Kramer Pharmaceuticals, Inc., Gerson Lehrman Group-, Inc., Guidepoint Global, LLC, Johnson & Johnson, H. Lundbeck, A/S, Moksha8 Pharmaceuticals, Inc., Nestle (PamLab), Neuralstrim, Sage Pharmaceuticals, Agency for Healthcare Research and Quality, AssureRx Health, Inc., Avanir, Axome, Inc.
Research/Grants: Allergan, Inc., Janssen Pharmaceuticals, Inc., Pfizer, Inc., Takeda Pharmaceuticals, Acadia, Inc., Alkermes PLC, Johnson & Johnson, Intracellular, Inc., National Institutes of Health, Patient-Centered Outcomes Research Institute
Royalties: American Psychiatric Foundation, Guilford Publication, Herald House, W.W. Norton & Company, Inc.
Spouse: Peleton Advantage

Larry Culpepper, MD
Reported Relevant Financial Relationship:
Advisory Board: Eisai Inc., Merck & Co., Purdue Pharma, Shire, Alkermes Inc., Harmony Biosciences LLC, Jazz Pharmaceuticals, Sunovion Pharmaceuticals Inc., Supernus Pharmaceuticals
Consultant: Merck & Co., Alkermes Inc.

The planners and managers reported the following relevant financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Curtis P. Schreiber, MD
CME Content Reviewer
Primary Care Network

Reported Relevant Financial Relationship:
Advisory Board: Amgen
Consultant: Amgen
Research Grants: Amgen, Genentech, Roche
Speaker's Bureau: Amgen, Novartis

David Howard
Medical Director
PlatformQ Health Education, LLC

Has no relevant financial relationships to disclose

The following PCN planner and manager, Jill Hays, hereby state that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any relevant financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The opinions, ideas, recommendations, and perspectives expressed in this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, advisory boards or consultants.

Contact Information

Accreditation Support:
Please contact Primary Care Network at http://www.primarycarenetwork.org/.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive at 877-394-1306 or at Support@PsychiatryCareLive.com